|
RVPH Reviva Pharmaceuticals Holdings Inc 1742927 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-2,447,831.00 |
| Balance Sheet |
|
Current Assets
|
$21,140,590.00 |
|
Assets
|
$21,140,590.00 |
|
Current Liabilities
|
$5,933,345.00 |
|
Liabilities
|
$5,933,345.00 |
|
Equity
|
$15,207,245.00 |
|
Shares Out
|
13110377.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-5,916,698.00 |
| Market Analysis |
Market Cap
|
$6,424,084.73 |
|
Price
|
$0.48 |
|
BVPS
|
1.16 |
|
PB
|
0.42 |
|
EPS
|
-0.19 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:02 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:52 |
|
| Apr |
May |
Jun |
| 2026-03-30 |
-5.48 |
|
|
2026-05-13 |
-0.46 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.12 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.06 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RVPH documents filed with the SEC.
RVPH Filings
Clear
